How to buy Acer Therapeutics stock

Acer Therapeutics Inc is a biotechnology business based in the US. Acer Therapeutics shares (ACER) are listed on the NASDAQ and all prices are listed in US Dollars. Acer Therapeutics employs 20 staff and has a market cap (total outstanding shares value) of 0.00.

Acer Therapeutics share price

Use our graph to track the performance of ACER stocks over time.

Acer Therapeutics shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$2.04 - $5.84
50-day moving average	$3.12
200-day moving average	$3.03
Wall St. target price	$10.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-3.20

Buy Acer Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Acer Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Acer Therapeutics Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Acer Therapeutics financials

Gross profit TTM	$0
Return on assets TTM	-78.59%
Return on equity TTM	-172.11%
Profit margin	0%
Book value	$0.62
Market capitalisation	$41.8 million

TTM: trailing 12 months

Shorting Acer Therapeutics shares

There are currently 412,909 Acer Therapeutics shares held short by investors – that's known as Acer Therapeutics's "short interest". This figure is 26.3% up from 326,935 last month.

There are a few different ways that this level of interest in shorting Acer Therapeutics shares can be evaluated.

Acer Therapeutics's "short interest ratio" (SIR)

Acer Therapeutics's "short interest ratio" (SIR) is the quantity of Acer Therapeutics shares currently shorted divided by the average quantity of Acer Therapeutics shares traded daily (recently around 1.7 million). Acer Therapeutics's SIR currently stands at 0.24. In other words for every 100,000 Acer Therapeutics shares traded daily on the market, roughly 240 shares are currently held short.

However Acer Therapeutics's short interest can also be evaluated against the total number of Acer Therapeutics shares, or, against the total number of tradable Acer Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Acer Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Acer Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0437% of the tradable shares (for every 100,000 tradable Acer Therapeutics shares, roughly 44 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Acer Therapeutics.

Find out more about how you can short Acer Therapeutics stock.

Acer Therapeutics share dividends

We're not expecting Acer Therapeutics to pay a dividend over the next 12 months.

Have Acer Therapeutics's shares ever split?

Acer Therapeutics's shares were split on a 96:1000 basis on 20 September 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 96 shares. This wouldn't directly have changed the overall worth of your Acer Therapeutics shares – just the quantity. However, indirectly, the new 941.7% higher share price could have impacted the market appetite for Acer Therapeutics shares which in turn could have impacted Acer Therapeutics's share price.

Acer Therapeutics share price volatility

Over the last 12 months, Acer Therapeutics's shares have ranged in value from as little as $2.04 up to $5.84. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acer Therapeutics's is 1.2215. This would suggest that Acer Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Acer Therapeutics overview

Acer Therapeutics Inc. , a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was founded in 2013 and is headquartered in Newton, Massachusetts. .

Frequently asked questions

• What percentage of Acer Therapeutics is owned by insiders or institutions?

  Currently 15.339% of Acer Therapeutics shares are held by insiders and 34.579% by institutions.

• How many people work for Acer Therapeutics?

  Latest data suggests 20 work at Acer Therapeutics.

• When does the fiscal year end for Acer Therapeutics?

  Acer Therapeutics's fiscal year ends in December.

• Where is Acer Therapeutics based?

  Acer Therapeutics's address is: One Gateway Center, Newton, MA, United States, 02458

• What is Acer Therapeutics's ISIN number?

  Acer Therapeutics's international securities identification number is: US00444P1084

• What is Acer Therapeutics's CUSIP number?

  Acer Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00444P108